Structures by: Lahmidi S.

Total: 18

1-(3-Hydroxypropyl)-3-phenylquinoxalin-2(1<i>H</i>)-one

C17H16N2O2

Abad, NadeemRamli, YoussefLahmidi, SanaeEl Hafi, MohamedEssassi, El MokhtarMague, Joel T.

IUCrData (2018) 3, 11 x181633

a=8.1914(14)Å   b=9.5151(16)Å   c=17.781(3)Å

α=90°   β=94.880(2)°   γ=90°

2-Amino-5-methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-7(4<i>H</i>)-one

C6H7N5O

Lahmidi, SanaeEl Hafi, Mohamedkheira Sebbar, NadaAbad, NadeemEssassi, El MokhtarMague, Joel T.

IUCrData (2018) 3, 11 x181500

a=6.5921(14)Å   b=8.3935(18)Å   c=13.185(3)Å

α=92.023(3)°   β=98.309(3)°   γ=99.741(3)°

1-Methyl-4-phenyl-3-[4-(trifluoromethyl)phenyl]-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine

C19H13F3N4

El Hafi, MohamedBoulhaoua, MohammedLahmidi, SanaeRamli, YoussefEssassi, El MokhtarMague, Joel T.

IUCrData (2018) 3, 6 x180875

a=15.0553(10)Å   b=15.7338(12)Å   c=6.9701(5)Å

α=90°   β=99.540(4)°   γ=90°

Ethyl 2-(5-methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-7-yl)pent-4-enoate

C13H16N4O2

Lahmidi, SanaeEl Hafi, MohamedMoussaif, AhmedBenchidmi, MohammedEssassi, El MokhtarMague, Joel T.

IUCrData (2018) 3, 9 x181280

a=9.069(5)Å   b=13.319(7)Å   c=11.851(7)Å

α=90°   β=112.161(7)°   γ=90°

1-Methyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4(5<i>H</i>)-one

C6H6N4O

El Hafi, MohamedLahmidi, SanaeBoulhaoua, MohammedRamli, YoussefEssassi, El MokhtarMague, Joel T.

IUCrData (2018) 3, 3 x180483

a=3.8342(2)Å   b=5.5701(3)Å   c=15.0346(9)Å

α=93.396(4)°   β=92.812(4)°   γ=92.361(4)°

1-Benzyl-4-phenyl-1<i>H</i>-1,5-benzodiazepin-2(3<i>H</i>)-one

C22H18N2O

Essaghouani, AbdelhanineBoulhaoua, MohammedLahmidi, SanaeEl Hafi, MohamedEssassi, El MokhtarMague, Joel T.

IUCrData (2016) 1, 12 x161988

a=14.6973(7)Å   b=5.9179(3)Å   c=19.8537(9)Å

α=90°   β=93.4610(10)°   γ=90°

3,5-Diamino-4<i>H</i>-1,2,4-triazol-1-ium 4-nitrobenzoate dihydrate

C2H6N5,C7H4NO4,2(H2O)

Lahmidi, SanaeEssassi, El MokhtarBenchidmi, MohammedSaadi, MohamedEl Ammari, Lahcen

IUCrData (2017) 2, 2 x170159

a=7.2050(2)Å   b=19.8831(6)Å   c=9.7676(3)Å

α=90°   β=105.6910(10)°   γ=90°

2-(2-Amino-5-methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-7-yl)acetohydrazide monohydrate

C8H11N7O,H2O

Lahmidi, SanaeSebbar, Nada KheiraBoulhaoua, MohammedEssassi, El MokhtarMague, Joel T.Zouihri, Hafid

IUCrData (2016) 1, 6 x160870

a=7.2648(3)Å   b=8.7228(4)Å   c=8.9297(4)Å

α=82.834(2)°   β=71.465(2)°   γ=85.4780(10)°

(3<i>S</i>)-3,8-Dibromo-4-phenyl-2,3-dihydro-1<i>H</i>-1,5-benzodiazapin-2-one

C15H10Br2N2O

Essaghouani, AbdelhanineBoulhaoua, MohammedLahmidi, SanaeMohamed Abdelahi, Mohamed MokhtarEssassi, El MokhtarMague, Joel T.

IUCrData (2017) 2, 3 x170389

a=7.8931(8)Å   b=9.9295(10)Å   c=10.2411(11)Å

α=101.7510(10)°   β=105.968(2)°   γ=109.4820(10)°

3-Acetyl-2-methyl-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-4-one

C11H10N2O2

Lahmidi, SanaeAbad, NadeemBoulhaoua, MohammedSebbar, Nada KheiraEssassi, El MokhtarMague, Joel T.

IUCrData (2017) 2, 7 x170991

a=3.7716(6)Å   b=10.3959(15)Å   c=12.3280(18)Å

α=78.017(2)°   β=83.431(2)°   γ=81.266(2)°

(2<i>Z</i>)-2-Benzylidene-4-octadecyl-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one

C33H47NOS

Sebbar, Nada KheiraEllouz, MohamedLahmidi, SanaeHlimi, FouziaEssassi, El MokhtarMague, Joel T.

IUCrData (2017) 2, 5 x170695

a=33.8411(7)Å   b=4.71060(10)Å   c=18.0987(4)Å

α=90°   β=90.4700(10)°   γ=90°

5-Nitro-1-(prop-2-en-1-yl)-1<i>H</i>-indazole

C10H9N3O2

Boulhaoua, MohammedEssaghouani, AbdelhanineLahmidi, SanaeBenchidmi, MohammedEssassi, El MokhtarMague, Joel T.

IUCrData (2017) 2, 7 x171091

a=6.9549(5)Å   b=11.6778(9)Å   c=12.2165(9)Å

α=90°   β=90°   γ=90°

2-Methyl-3-(3-methylisoxazol-5-yl)-4-oxo-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-1-ium chloride

C13H12N3O2,Cl

Lahmidi, SanaeEl Ouasif, LatifaJilalat, Alae EddineAl-Garadi, WedadEssassi, El MokhtarMague, Joel T.

IUCrData (2016) 1, 12 x161978

a=6.2796(12)Å   b=9.6912(18)Å   c=21.152(4)Å

α=90°   β=95.294(3)°   γ=90°

5-[(5-Nitro-1<i>H</i>-indazol-1-yl)methyl]-3-phenyl-4,5-dihydroisoxazole

C17H14N4O3

Boulhaoua, MohammedKansiz, SevgiEl Hafi, MohamedLahmidi, SanaeDege, NecmiBenchidmi, MohammedMague, Joel T.

Acta Crystallographica Section E (2019) 75, 1 71-74

a=7.8595(4)Å   b=11.8831(7)Å   c=15.5716(9)Å

α=90°   β=101.8530(10)°   γ=90°

5-Methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidine

C6H6N4

Lahmidi, SanaeSebbar, Nada KheiraHökelek, TuncerChkirate, KarimMague, Joel T.Essassi, El Mokhtar

Acta Crystallographica Section E (2018) 74, 12 1833-1837

a=3.7910(2)Å   b=18.0092(10)Å   c=9.0069(5)Å

α=90°   β=101.704(2)°   γ=90°

3-(4-Methoxyphenyl)-1-methyl-4-phenyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine

C19H16N4O

El Hafi, MohamedKansiz, SevgiLahmidi, SanaeBoulhaoua, MohammedRamli, YoussefDege, NecmiEssassi, El MokhtarMague, Joel T.

Acta Crystallographica Section E (2019) 75, 5 638-641

a=6.5227(3)Å   b=7.8979(4)Å   c=30.7774(15)Å

α=90°   β=95.389(2)°   γ=90°

(<i>Z</i>)-7,8-Dichloro-4-(2-oxopropylidene)-4,5-dihydro-1<i>H</i>-1,5-benzodiazepin-2(3<i>H</i>)-one

C12H10Cl2N2O2

Lahmidi, SanaeEssaghouani, AbdelhanineEssassi, El MokhtarSaadi, MohamedEl Ammari, Lahcen

Acta Crystallographica Section E (2015) 71, 12 o1059-o1060

a=7.6789(4)Å   b=13.2199(6)Å   c=12.4129(7)Å

α=90°   β=102.561(3)°   γ=90°